Mainz Biomed B.V. UNDERWRITING AGREEMENTUnderwriting Agreement • October 12th, 2021 • Mainz Biomed B.V. • Pharmaceutical preparations • New York
This underwriting agreement (this “Agreement”) constitutes the agreement between Mainz Biomed B.V., a Dutch company limited by shares (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereafter defined) as being subsidiaries or affiliates of the Company, the “Company”) on the one hand, and Boustead Securities, LLC (the “Underwriter”), on the other hand, pursuant to which the Underwriter shall serve as the underwriter for the Company in connection with the proposed offering (the “Offering”) by the Company of their Securities (as defined below) on a “Firm Commitment” basis.
DATED 29 JULY 2021 CONTRIBUTION AGREEMENTContribution Agreement • October 12th, 2021 • Mainz Biomed B.V. • Pharmaceutical preparations
Silent Partnership Agreement Between the Company PharmGenomics GmbH, Robert- Koch-Str. 50, 55129 Mainz, Germany - hereinafter also referred to as the “Participant” - and the - hereinafter also referred to as the “Participation Provider” - OverviewSilent Partnership Agreement • October 12th, 2021 • Mainz Biomed B.V. • Pharmaceutical preparations
Amendment to License AND DEVELOPMENT agreementLicense and Development Agreement • October 12th, 2021 • Mainz Biomed B.V. • Pharmaceutical preparations
This amendment refers to the License and Development Agreement entered into the 1st of January, 2019 (the ”Agreement”) between the parties:
LICENSE and DEVELOPMENT AGREEMENT between ColoAlert AS and PharmGenomics GmbHLicense and Development Agreement • October 12th, 2021 • Mainz Biomed B.V. • Pharmaceutical preparations
